Edition:
India

Novus Therapeutics Inc (NVUS.OQ)

NVUS.OQ on NASDAQ Stock Exchange Capital Market

6.93USD
20 Jul 2018
Change (% chg)

$0.42 (+6.45%)
Prev Close
$6.51
Open
$6.55
Day's High
$6.93
Day's Low
$6.55
Volume
713
Avg. Vol
10,095
52-wk High
$8.61
52-wk Low
$3.13

Latest Key Developments (Source: Significant Developments)

Novus Therapeutics Inc reported Q3 $0.43 loss per share​
Thursday, 9 Nov 2017 

Nov 8 (Reuters) - Novus Therapeutics Inc :Novus Therapeutics Inc - ‍for Q3 of 2017, Novus reported $0.43 loss per share​.  Full Article

Novus Therapeutics reports third quarter 2017 results
Thursday, 9 Nov 2017 

Nov 8 (Reuters) - Novus Therapeutics Inc :Novus Therapeutics reports third quarter 2017 results.Q3 loss per share $0.43.  Full Article

Tokai Pharmaceuticals appoints John S. Mcbride CFO
Wednesday, 3 Aug 2016 

Tokai Pharmaceuticals Inc : Lee H. Kalowski, chief financial officer will cease employment effective august 31, 2016 - SEC filing . CFO, EVP, business operations and general counsel, will cease employment in relation to previously announced workforce reduction . Previously announced retirement of Karen J. Ferrante, chief medical officer, will become effective on august 31, 2016 .Appointed John S. Mcbride chief financial officer effective September 1, 2016.  Full Article

BRIEF-Novus Therapeutics Reports Q4 Loss Per Share $0.30

* Q4 LOSS PER SHARE $0.30 Source text for Eikon: Further company coverage: (Reuters.Brief@thomsonreuters.com)